2019

Families USA Joins Oral Health, Senior Advocates in Support of Medicare Dental Benefit Act

Families USA is encouraged to see oral health coming up early in the 116th Congress with Senator Cardin introducing S. 22, the Medicare Dental Benefit Act of 2019 earlier this week. This legislation s...

A Deep Dive into the Connections Between Oral and Behavioral Health

Oral health is an important aspect of overall health and influences physical and mental well-being, but receives less of its fair share of attention and resources. For people with mental health condit...

Oral Health for All: Addressing Dental Coverage for Grownups in Congress and the States

Oral health coverage for adults is excluded from Medicare and minimal in most state Medicaid programs. Luckily, some federal and state lawmakers are realizing what we all know—that oral health is cr...

Families USA’s Comments on Proposed Rule on Medicare Part D Protected Classes

Late last year, the Trump administration released a proposed rule as part of its efforts to lower prescription drug prices that, if finalized, could have a significant impact on Medi...

Families USA Comments on Safe Harbor Rule

Families USA submitted this comment to Secretary Azar on the proposed safe harbor rule changes. Under the proposed rule, discounts awarded by prescription drug manufacturers to plan sponsors under M...

Letter to Congress: Strengthening Health Care and Lowering Prescription Drug Costs Act.

Families USA submitted the attached letter to U.S. House of Representatives Leadership in support of H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act....

Frederick Isasi’s Testimony on High Drug Prices to the House Energy and Commerce Committee

In this testimony before the U.S. House of Representatives Energy and Commerce Committee on May 21, 2019, Frederick Isasi, Executive Director of Families USA, breaks down the problem with high drug ...

Medicare’s Drug Benefit: With Regulatory Action Off the Table, All Eyes Are on Capitol Hill

On May 16th, the Centers for Medicare and Medicaid Services announced a final regulation for Medicare’s Part D drug benefit for 2020. The regulation backed off of a proposal that would have crea...

Representative Doggett’s Medicare Negotiation Proposal to Meaningfully Lower Drug Prices

High and rising drug prices jeopardize consumers’ health and well-being.1 To address the harms of high drug prices, families across America want and deserve meaningful reforms that target and reduc...